{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:05:34Z","timestamp":1790939134260,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/sj.bjc.6605269","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T22:46:14Z","timestamp":1253054774000},"page":"S6-S10","source":"Crossref","is-referenced-by-count":38,"title":["Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors"],"prefix":"10.1038","volume":"101","author":[{"given":"S","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,15]]},"reference":[{"key":"BF6605269_CR1","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","volume":"42","author":"MS Aapro","year":"2006","unstructured":"Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman GH, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinskil C, European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party (2006) EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 42: 2433\u20132453","journal-title":"Eur J Cancer"},{"key":"BF6605269_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJM199504063321401","volume":"332","author":"G Bonadonna","year":"1995","unstructured":"Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C (1995) Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. N Engl J Med 332: 901\u2013906","journal-title":"N Engl J Med"},{"key":"BF6605269_CR3","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1200\/JCO.2005.05.059","volume":"23","author":"J Bonneterre","year":"2005","unstructured":"Bonneterre J, Roch\u00e9 H, Kerbrat P, Br\u00e9mond A, Fumoleau P, Namer M, Goudier MJ, Schraub S, Fargeot P, Chapelle-Marcillac I (2005) Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial. J Clin Oncol 23: 2686\u20132693","journal-title":"J Clin Oncol"},{"key":"BF6605269_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/cncr.20757","volume":"103","author":"E Bria","year":"2005","unstructured":"Bria E, Giannarelli D, Felici A, Peters WP, Nistic\u00f2 C, Vanni B, Cuppone F, Cognetti F, Terzoli E (2005) Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma. Cancer 103: 672\u2013679","journal-title":"Cancer"},{"issue":"Suppl 1","key":"BF6605269_CR5","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/sj.bjc.6605272","volume":"101","author":"D Cameron","year":"2009","unstructured":"Cameron D (2009) Management of chemotherapy-associated febrile neutropenia. Br J Cancer 101(Suppl 1): S18\u2013S22","journal-title":"Br J Cancer"},{"key":"BF6605269_CR6","doi-asserted-by":"crossref","unstructured":"Chirivella I, Bermejo A, Insa A, Perez-Fidalgo A, Magro A, Rosello S, Garcia-Garre E, Martin P, Bosch A, Lluch A (2006) Impact of chemotherapy dose-related factors on survival in breast cancer patients treated with adjuvant anthracycline-based chemotherapy. J Clin Oncol 24: Abstract 668","DOI":"10.1200\/jco.2006.24.18_suppl.668"},{"key":"BF6605269_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1056\/NEJM199107183250305","volume":"325","author":"J Crawford","year":"1991","unstructured":"Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N Engl J Med 325: 164\u2013170","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"BF6605269_CR8","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/sj.bjc.6605270","volume":"101","author":"M Cullen","year":"2009","unstructured":"Cullen M, Baijal S (2009) Prevention of febrile neutropenia: use of prophylactic antibiotics. Br J Cancer 101(Suppl 1): S11\u2013S14","journal-title":"Br J Cancer"},{"key":"BF6605269_CR9","volume-title":"Feasibility of Adjuvant Treatment with Docetaxel\/Doxorubicin\/Cyclophosphamide (the TAC regime) in Routine Clinical Practice","author":"I Gounaris","year":"2008","unstructured":"Gounaris I, Macleod P, Kelly S (2008) Feasibility of Adjuvant Treatment with Docetaxel\/Doxorubicin\/Cyclophosphamide (the TAC regime) in Routine Clinical Practice. Plymouth Hospitals NHS Trust: Plymouth"},{"key":"BF6605269_CR10","first-page":"CD007107","volume":"21","author":"C Herbst","year":"2009","unstructured":"Herbst C, Naumann F, Kruse EB, Monsef I, Bohlius J, Schulz H, Engert A (2009) Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. Cochrane Database Syst Rev 21: CD007107","journal-title":"Cochrane Database Syst Rev"},{"key":"BF6605269_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/annonc\/mdl292","volume":"17","author":"PS Hupperets","year":"2006","unstructured":"Hupperets PS, Tjan-Heijnen VC (2006) Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer? Ann Oncol 17: 1181\u20131183","journal-title":"Ann Oncol"},{"key":"BF6605269_CR12","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1517\/14712598.4.12.1897","volume":"4","author":"RS Komrokji","year":"2004","unstructured":"Komrokji RS, Lyman GH (2004) The colony stimulating factors: use to prevent and treat neutropenia and its complications. Expert Opin Bio Ther 4: 1897\u20131910","journal-title":"Expert Opin Bio Ther"},{"key":"BF6605269_CR13","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106: 2258\u20132266","journal-title":"Cancer"},{"key":"BF6605269_CR14","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","volume":"25","author":"NM Kuderer","year":"2007","unstructured":"Kuderer NM, Dale DC, Crawford J, Lyman GH (2007) Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25: 3158\u20133167","journal-title":"J Clin Oncol"},{"key":"BF6605269_CR15","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1038\/sj.bjc.6601279","volume":"89","author":"RCF Leonard","year":"2003","unstructured":"Leonard RCF, Miles D, Thomas R, Nussey F, UK Breast Cancer Neutropenia Audit Group (2003) Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patients. Br J Cancer 89: 2062\u20132068","journal-title":"Br J Cancer"},{"key":"BF6605269_CR16","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/j.ejca.2007.08.005","volume":"43","author":"WJ Louwman","year":"2007","unstructured":"Louwman WJ, Vulto JCM, Verhoeven RHA, Nieuwenhuijzen GAP, Coebergh JWW, Voogd AC (2007) Clinical epidemiology of breast cancer in the elderly. Eur J Cancer 43: 2242\u20132252","journal-title":"Eur J Cancer"},{"key":"BF6605269_CR17","unstructured":"Lyman GH, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC, for the ANC Study Group (2007) A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy. J Clin Oncol 23: Abstract: 8122"},{"key":"BF6605269_CR18","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/cncr.11827","volume":"98","author":"GH Lyman","year":"2003","unstructured":"Lyman GH, Dale DJ (2003) Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin's lymphoma. Cancer 98: 2402\u20132409","journal-title":"Cancer"},{"key":"BF6605269_CR19","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMoa043681","volume":"352","author":"M Martin","year":"2005","unstructured":"Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al-Tweigeri T, Chap L, Juhos E, Guevin R, Howell A, Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwell B, Prady C, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M, Riva A, Vogel C, Breast Cancer International Research Group 001 Investigators (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352: 2302\u20132313","journal-title":"N Engl J Med"},{"key":"BF6605269_CR20","unstructured":"Oncologist Breast Cancer Study (2008) sanofi-aventis. Data on file"},{"key":"BF6605269_CR21","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","volume":"18","author":"H Ozer","year":"2000","unstructured":"Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Somerfield MR, for the American Society of Clinical Oncology Growth Factors Expert Panel (2000) 2000 Update of recommendations for the use of haematopoietic colony stimulating factors: evidence based, clinical practice guidelines. J Clin Oncol 18: 3558\u20133585","journal-title":"J Clin Oncol"},{"key":"BF6605269_CR22","unstructured":"Peto R, on behalf of the Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2007) The worldwide Oxford overview: Updated (2005\u20132006) meta-analyses of trial results. San Antonio Breast Cancer Symposium"},{"key":"BF6605269_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.6004\/jnccn.2008.0013","volume":"6","author":"BH Segal","year":"2008","unstructured":"Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke E, Gelfand M, Greene JN, Ison MG, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marcucci G, Montoya JG, Engemann AM, Rolston K, The AS (2008) Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 6: 122\u2013174","journal-title":"J Natl Compr Canc Netw"},{"key":"BF6605269_CR24","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","volume":"24","author":"TJ Smith","year":"2006","unstructured":"Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24: 3187\u20133205","journal-title":"J Clin Oncol"},{"key":"BF6605269_CR25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1200\/JCO.2005.09.102","volume":"23","author":"CL Vogel","year":"2005","unstructured":"Vogel CL, Wojtukiewicz MZ, Carroll RR, Tjulandin SA, Barajas-Figueroa LJ, Wiens BL, Neumann TA, Schwartzberg LS (2005) First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol 23: 1178\u20131184","journal-title":"J Clin Oncol"},{"key":"BF6605269_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/annonc\/mdm438","volume":"19","author":"G von Minckwitz","year":"2008","unstructured":"von Minckwitz G, Kummel S, du Bois A, Eiermann W, Eidtmann H, Gerber B, Hilfrich J, Huober J, Costa SD, Jackisch C, Grasshoff ST, Vescia S, Skacel T, Loibl S, Mehta KM, Kaufmann M, German Breast Group (2008) Pegfilgrastim\u00b1ciprofloxacin for primary prophylaxis with TAC (docetaxel\/doxorubicin\/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. Ann Oncol 19: 292\u2013298","journal-title":"Ann Oncol"},{"key":"BF6605269_CR27","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ejca.2007.06.001","volume":"43","author":"U Wedding","year":"2007","unstructured":"Wedding U, Pientka L, Hoffken K (2007) Quality-of-life in elderly patients with cancer: a short review. Eur J Cancer 43: 2203\u20132210","journal-title":"Eur J Cancer"},{"key":"BF6605269_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM199405053301801","volume":"330","author":"WC Wood","year":"1994","unstructured":"Wood WC, Budman DR, Korzun AH, Cooper MR, Younger J, Hart RD, Moore A, Ellerton JA, Norton L, Ferree CR, Colangelo Ballow A, Frei E, Henderson IC (1994) Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med 330: 1253\u20131259","journal-title":"N Engl J Med"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605269","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:41:35Z","timestamp":1684413695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":28,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BF6605269"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605269","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}